Electroporation-Based Treatments in Small Animal Veterinary Oral and Maxillofacial Oncology

被引:12
作者
Nemec, Ana [1 ]
Milevoj, Nina [1 ]
Tratar, Ursa Lampreht [2 ]
Sersa, Gregor [2 ]
Cemazar, Maja [2 ]
Tozon, Natasa [1 ]
机构
[1] Univ Ljubljana, Vet Fac, Small Anim Clin, Ljubljana, Slovenia
[2] Inst Oncol Ljubljana, Ljubljana, Slovenia
关键词
electroporation; electrochemotherapy (ECT); gene electrotransfer; oral tumors; dogs; cats; SQUAMOUS-CELL CARCINOMA; GENE ELECTROTRANSFER; MALIGNANT-MELANOMA; PROGNOSTIC-FACTORS; ANTITUMOR EFFECTIVENESS; SPONTANEOUS NEOPLASMS; ELECTROGENE THERAPY; ELECTROCHEMOTHERAPY; DOGS; INTERLEUKIN-12;
D O I
10.3389/fvets.2020.575911
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Electroporation is a method of inducing an increase in permeability of the cell membrane through the application of an electric field and can be used as a delivery method for introducing molecules of interest (e.g., chemotherapeutics or plasmid DNA) into cells. Electroporation-based treatments (i.e., electrochemotherapy, gene electrotransfer, and their combinations) have been shown to be safe and effective in veterinary oncology, but they are currently mostly recommended for the treatment of those solid tumors for which clients have declined surgery and/or radiotherapy. Published data show that electroporation-based treatments are also safe, simple, fast and cost-effective treatment alternatives for selected oral and maxillofacial tumors, especially small squamous cell carcinoma and malignant melanoma tumors not involving the bone in dogs. In these patients, a good local response to treatment is expected to result in increased survival time with good quality of life. Despite emerging evidence of the clinical efficacy of electroporation-based treatments for oral and maxillofacial tumors, further investigation is needed to optimize treatment protocols, improve clinical data reporting and better understand the mechanisms of patients' response to the treatment.
引用
收藏
页数:17
相关论文
共 110 条
  • [1] André FM, 2008, HUM GENE THER, V19, P1261, DOI 10.1089/hgt.2008.060
  • [2] The significance of microbiome in personalized medicine
    Behrouzi, Ava
    Nafari, Amir Hossein
    Siadat, Seyed Davar
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2019, 8
  • [3] European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results of the treatment of skin cancer
    Bertino, Giulia
    Sersa, Gregor
    De Terlizzi, Francesca
    Occhini, Antonio
    Plaschke, Christina Caroline
    Groselj, Ales
    Langdon, Cristobal
    Grau, Juan J.
    McCaul, James A.
    Heuveling, Derrek
    Cemazar, Maja
    Strojan, Primoz
    de Bree, Remco
    Leemans, C. Rene
    Wessel, Irene
    Gehl, Julie
    Benazzo, Marco
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 63 : 41 - 52
  • [4] Electrochemotherapy - Emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration
    Campana, Luca G.
    Edhemovic, Ibrahim
    Soden, Declan
    Perrone, Anna M.
    Scarpa, Marco
    Campanacci, Laura
    Cemazar, Maja
    Valpione, Sara
    Miklavcic, Damijan
    Mocellin, Simone
    Sieni, Elisabetta
    Sersa, Gregor
    [J]. EJSO, 2019, 45 (02): : 92 - 102
  • [5] Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review
    Campana, Luca G.
    Clover, A. James P.
    Valpione, Sara
    Quaglino, Pietro
    Gehl, Julie
    Kunte, Christian
    Snoj, Marko
    Cemazar, Maja
    Rossi, Carlo R.
    Miklavcic, Damijan
    Sersa, Gregor
    [J]. RADIOLOGY AND ONCOLOGY, 2016, 50 (01) : 1 - 13
  • [6] The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study
    Campana, Luca G.
    Valpione, Sara
    Falci, Cristina
    Mocellin, Simone
    Basso, Michela
    Corti, Luigi
    Balestrieri, Nicola
    Marchet, Alberto
    Rossi, Carlo R.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1169 - 1178
  • [7] Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours
    Cemazar, M.
    Avgustin, J. Ambrozic
    Pavlin, D.
    Sersa, G.
    Poli, A.
    Levacic, A. Krhac
    Tesic, N.
    Tratar, U. Lampreht
    Rak, M.
    Tozon, N.
    [J]. VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (02) : 641 - 654
  • [8] Cancer Electrogene Therapy with Interleukin-12
    Cemazar, Maja
    Jarm, Tomaz
    Sersa, Gregor
    [J]. CURRENT GENE THERAPY, 2010, 10 (04) : 300 - 311
  • [9] Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model
    Chuang, Tien-Fu
    Lee, Shan-Chih
    Liao, Kuang-Wen
    Hsiao, Ya-Wen
    Lo, Chia-Hui
    Chiang, Bor-Luen
    Lin, Xi-Zhang
    Tan, Mi-Hua
    Chu, Rea-Min
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) : 698 - 707
  • [10] Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer
    Cicchelero, L.
    Denies, S.
    Haers, H.
    Vanderperren, K.
    Stock, E.
    Van Brantegem, L.
    de Rooster, H.
    Sanders, N. N.
    [J]. VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1187 - 1205